Appendix 3H - Notification of cessation of securitiesAppendix 3H - Notification of cessation of securities1 / 4Announcement SummaryEntity namePARADIGM BIOPHARMACEUTICALS LIMITED..Announcement TypeNew announcementDate of this announcementThursday September 24, 2026Details of +securities that have...
Notification of cessation of securities - PAR
Filed with ASX · · 4 pages · English
Release
Paradigm Biopharmaceuticals Ltd. on 6ix
Earlier from Paradigm Biopharmaceuticals
- Phase 3 Interim Result Below Continuation Threshold
- Suspension from Quotation
- Trading Halt
- Application for quotation of securities - PAR
- Dr Daniel Furtner appointed Chief Medical Officer
Later from Paradigm Biopharmaceuticals
- Agreement to Return US$2M to Obsidian
- Continuation of Voluntary Suspension
- Board Initiates Voluntary Administration
- Appointment of Voluntary Administrators
- Continuation of Suspension from Quotation
Follow Paradigm Biopharmaceuticals into a list and get an email when it puts out news.
Follow Paradigm Biopharmaceuticals